Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 1/20 | 0.41 |
| ▸ | ATAD2 | Q6PL18 | 2/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.32 |
| ▸ | ADRA1B | P35368 | 4/20 | 0.32 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6561465 | 0.75 | — | — | |
| SCHEMBL17490535 | 0.74 | SLC9A1 (0.44) | SLC9A1ATAD2ALDH1A1NOTUMKDM4E | |
| SCHEMBL22107468 | 0.74 | SLC9A1 (0.40) | SLC9A1ATAD2NOTUM | |
| SCHEMBL15031427 | 0.74 | SLC9A1 (0.40) | SLC9A1ATAD2NOTUM | |
| SCHEMBL7141528 | 0.74 | SLC9A1 (0.40) | SLC9A1ATAD2NOTUM | |
| SCHEMBL24712473 | 0.74 | SLC9A1 (0.40) | SLC9A1ATAD2NOTUM | |
| SCHEMBL15663365 | 0.74 | SLC9A1 (0.40) | SLC9A1ATAD2NOTUM | |
| SCHEMBL16652006 | 0.74 | ADORA2A (0.36) | ADORA2AADORA2BADORA3ADORA1CYP3A4 | |
| SCHEMBL2078821 | 0.74 | ADORA2A (0.36) | ADORA2AADORA2BADORA3ADORA1CYP3A4 | |
| SCHEMBL9685966 | 0.74 | ALDH1A1 (0.37) | ADORA2AADORA2BADORA3ADORA1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119381591-A | Zinc metal self-repairing high-performance fibrous flexible water-based zinc battery and preparation method thereof | 中国电子科技集团公司第十八研究所 | 2025-01-28 | — | — | CN | claimed |
| EP-4357461-A2 | DETERMINATION OF BASE MODIFICATIONS OF NUCLEIC ACIDS | The Chinese University Of Hong Kong (CN) | 2024-04-24 | — | — | EP | claimed |
| EP-3827092-B1 | DETECTION OF METHYLATION OF NUCLEOTIDES IN NUCLEIC ACIDS | UNIV HONG KONG CHINESE (CN) | 2024-01-31 | — | — | EP | claimed |
| CN-112752853-B | Determination of base modification of nucleic acids | 香港中文大学 | 2023-06-30 | — | — | CN | claimed |
| CN-115508408-A | Method for rapidly determining concentration of 6-amino 1,3 dimethyl uracil by differential scanning calorimetry | 慧科高新科技股份有限公司 | 2022-12-23 | — | — | CN | claimed |
| EP-3827092-A1 | DETERMINATION OF BASE MODIFICATIONS OF NUCLEIC ACIDS | The Chinese University Of Hong Kong (CN) | 2021-06-02 | — | — | EP | claimed |
| CN-112752853-A | Determination of base modifications of nucleic acids | 香港中文大学 | 2021-05-04 | — | — | CN | claimed |
| WO-2021032060-A1 | DETERMINATION OF BASE MODIFICATIONS OF NUCLEIC ACIDS | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2021-02-25 | — | — | WO | claimed |
| CN-106046004-B | A kind of total synthesis method of 1,3,7,9- tetramethyluric acids | 上海佰特因医药科技有限公司 | 2018-05-15 | — | — | CN | claimed |
| EP-3157573-A2 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | Moderna Therapeutics, Inc. (US) | 2017-04-26 | — | — | EP | claimed |
| CN-1349133-A | Developer solution for silver salt diffusing and transferring aluminium-base offset plate and its use | INST OF PHOTOCHEMISTRY CHINESE (CN) | 2002-05-15 | — | — | CN | claimed |
| US-20020055506-A1 | Methods for treatment of disease-induced peripheral neuropathy and related conditions | SPECTRUM PHARMACEUTICALS, INC. | 2002-05-09 | — | — | US | claimed |
| US-20020040031-A1 | Methods for prevention of accumulation of amyloid beta peptide in the central nervous system | NEO THERAPEUTICS, INC. | 2002-04-04 | — | — | US | claimed |
| US-20020040032-A1 | Methods for stimulation of synthesis of synaptophysin in the central nervous system | NEOTHERAPEUTICS, INC. | 2002-04-04 | — | — | US | claimed |
| WO-2002004450-A2 | METHODS FOR PREVENTION OF ACCUMULATION OF AMYLOID BETA PEPTIDE IN THE CENTRAL NERVOUS SYSTEM | NEOTHERAPEUTICS, INC. (US) | 2002-01-17 | — | — | WO | claimed |
| WO-2002004452-A2 | METHODS FOR TREATMENT OF DISEASE-INDUCED PERIPHERAL NEUROPATHY AND RELATED CONDITIONS | NEOTHERAPEUTICS, INC. (US) | 2002-01-17 | — | — | WO | claimed |
| WO-2002004449-A2 | METHODS FOR TREATMENT OF CONDITIONS AFFECTED BY ACTIVITY OF MULTIDRUG TRANSPORTERS | NEOTHERAPEUTICS, INC. (US) | 2002-01-17 | — | — | WO | claimed |
| WO-2002004451-A2 | METHODS FOR STIMULATION OF SYNTHESIS OF SYNAPTOPHYSIN IN THE CENTRAL NERVOUS SYSTEM | NEOTHERAPEUTICS, INC. (US) | 2002-01-17 | — | — | WO | claimed |
| WO-2002004448-A2 | METHODS FOR TREATMENT OF DRUG-INDUCED PERIPHERAL NEUROPATHY AND RELATED CONDITIONS | NEOTHERAPEUTICS, INC. (US) | 2002-01-17 | — | — | WO | claimed |
| WO-1994015622-A1 | NUCLEOSIDE DERIVATIVES AND THEIR USE AS EXCITATORY AMINO ACID ANTAGONISTS | CAMBRIDGE NEUROSCIENCE (US) | 1994-07-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020055506-A1 | Methods for treatment of disease-induced peripheral neuropathy and related conditions | NGF, NUDT1, HPRT1 | SLC9A1 3214/4885ATAD2 4545/4885ADORA2A 241/4885 |
| US-20020040032-A1 | Methods for stimulation of synthesis of synaptophysin in the central nervous system | GAP43, BDNF, APP | SLC9A1 2454/4885ATAD2 3944/4885ADORA2A 235/4885 |
| US-20020040031-A1 | Methods for prevention of accumulation of amyloid beta peptide in the central nervous system | APP, BACE1, SARNP | SLC9A1 3159/4885ATAD2 2203/4885ADORA2A 658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.